2026 | Verified Q&A | Graded A+
1. If a 60-year-old woman, five years post-menopause, is prescribed Calcitonin
for osteoporosis, what outcome should be expected from this treatment?
No change in bone mineral density
An increase in bone mineral density at the spine
An increase in calcium levels in the blood
A decrease in bone mineral density at the hip
2. What is the primary metabolic abnormality associated with gout?
Low calcium levels
Increased glucose levels
High cholesterol levels
Excessive uric acid in the blood
3. Describe the significance of vitamin D intake for adults aged 50 and older in
relation to bone health.
Vitamin D is only important for children and has no effect on adults.
Vitamin D intake is only necessary for those with existing bone
disorders.
Vitamin D does not play a role in calcium absorption.
Adequate vitamin D intake is crucial for maintaining bone health
and preventing osteoporosis in adults aged 50 and older.
,4. Discuss how chronic conditions like renal impairment can affect the
management of gout.
Chronic renal impairment requires the use of more potent medications
for gout.
Chronic renal impairment has no effect on gout management.
Chronic renal impairment can affect the elimination of uric acid,
necessitating adjustments in gout medication dosages.
Chronic renal impairment allows for higher doses of gout medications.
5. Describe how hormone replacement therapy contributes to the management
of osteoporosis in postmenopausal women.
Hormone replacement therapy contributes to osteoporosis
management by maintaining bone density and lowering the risk of
fractures.
Hormone replacement therapy is used to increase muscle mass in
postmenopausal women.
Hormone replacement therapy is only effective in premenopausal
women.
Hormone replacement therapy primarily focuses on pain relief
without affecting bone density.
6. If a patient experiences a gout attack and delays taking colchicine, what
might be the expected outcome regarding the effectiveness of the
treatment?
Increased effectiveness of the treatment
Reduced effectiveness of the treatment
No change in treatment effectiveness
, Complete resolution of symptoms
7. In addition to the appropriate pharmacologic treatment, which
nonpharmacologic therapy is best to recommend for pts with gout?
Avoiding exercise.
Limiting alcohol consumption to less than 2 drinks per day for men
and less than 1 drink per day for women.
Incorporating high-fat dairy products into diet.
Consuming organ meats high in purine (e.g., liver, kidney).
8. What are common symptoms associated with osteoarthritis?
Joint pain and stiffness
Nausea and vomiting
Skin rash and itching
Fatigue and fever
9. Which medications are considered first-line treatments for acute gout
attacks?
Antidepressants and antipsychotics
Antibiotics and analgesics
Opioids and muscle relaxants
NSAIDs, colchicine, and corticosteroids
10. Which gender is more commonly associated with a higher risk of developing
osteoporosis?
Male gender
, Transgender gender
Non-binary gender
Female gender
11. If a patient with gout is advised to increase their hydration, what is the
expected outcome of this intervention?
Increased joint swelling
Reduced uric acid levels
Decreased mobility in joints
Higher risk of gout attacks
12. An appropriate goal of treatment during osteoporosis management
includes:
Decrease risk of hip and vertebral factures
Decrease bone mineral density
Increase osteoclast activity
Increase Vitamin D concentration above 150 ng/mL
13. What are the three first-line therapies for an acute gout attack as per ACR
guidelines?
Corticosteroids, bisphosphonates, and colchicine
NSAIDs, colchicine, and corticosteroids
Bisphosphonates, NSAIDs, and corticosteroids
Colchicine, hormone replacement therapy, and NSAIDs